Pediatrix Medical (MD) Liabilities and Shareholders Equity (2009 - 2026)

Pediatrix Medical (MD) has reported Liabilities and Shareholders Equity for 18 consecutive years, with $2.1 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 3.85% year-over-year to $2.1 billion; the TTM figure through Mar 2026 stood at $8.6 billion (up 4.87% YoY), while the FY2025 annual figure was $2.2 billion, up 4.37% from the prior year.
• Liabilities and Shareholders Equity slipped to $2.1 billion in Q1 2026 per MD's latest filing, from $2.2 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $2.4 billion in Q2 2022 and bottomed at $2.0 billion in Q1 2025.
• Historically, Liabilities and Shareholders Equity has averaged $2.2 billion across 5 years, with a median of $2.2 billion in 2023.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity fell 13.76% — and 2025, when it rose 5.9%.
• Pediatrix Medical's Liabilities and Shareholders Equity stood at $2.3 billion in 2022, then slipped by 5.45% to $2.2 billion in 2023, then dropped by 3.02% to $2.2 billion in 2024, then advanced by 4.37% to $2.2 billion in 2025, then retreated by 7.85% to $2.1 billion in 2026.
• Business Quant data shows MD's Liabilities and Shareholders Equity at $2.1 billion in Q1 2026, $2.2 billion in Q4 2025, and $2.2 billion in Q3 2025.